Brief: Jasper Therapeutics Announces Pricing Of $50 Million Underwritten Offering Of Common Stock
06/02/2024 14:20
Feb 6 (Reuters) - Jasper Therapeutics Inc JSPR.O :
* JASPER THERAPEUTICS ANNOUNCES PRICING OF $50 MILLION
UNDERWRITTEN OFFERING OF COMMON STOCK
* JASPER THERAPEUTICS INC: EACH SHARE OF COMMON STOCK WILL
BE SOLD
AT AN OFFERING PRICE OF $12.95 PER SHARE
* JASPER THERAPEUTICS : ANNOUNCED PRICING OF ITS
UNDERWRITTEN
OFFERING OF 3.9 MILLION SHARES OF ITS COMMON STOCK
Source text for Eikon: ID:nGNX71038K
Further company coverage: JSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma